Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
26,039
+3,074
+13% +$217K 0.01% 609
2025
Q4
$1.55M Sell
22,965
-2,433
-10% -$164K 0.01% 595
2025
Q3
$1.86M Sell
25,398
-6
-0% -$399 0.01% 563
2025
Q2
$1.32M Buy
25,404
+6,752
+36% +$384K 0.01% 634
2025
Q1
$1.19M Buy
18,652
+198
+1% +$11.5K 0.01% 635
2024
Q4
$882K Buy
18,454
+1,051
+6% +$53.9K 0.01% 765
2024
Q3
$996K Sell
17,403
-359
-2% -$20.6K 0.01% 703
2024
Q2
$930K Sell
17,762
-1,101
-6% -$48.3K 0.01% 693
2024
Q1
$767K Buy
18,863
+131
+0.7% +$4.91K 0.01% 797
2023
Q4
$692K Sell
18,732
-153
-0.8% -$5.76K 0.01% 814
2023
Q3
$721K Sell
18,885
-506
-3% -$20.7K 0.01% 762
2023
Q2
$699K Sell
19,391
-1,568
-7% -$53.5K 0.01% 778
2023
Q1
$800K Buy
20,959
+91
+0.4% +$4.27K 0.01% 733
2022
Q4
$1.19M Sell
20,868
-484
-2% -$24.8K 0.02% 581
2022
Q3
$844K Buy
21,352
+68
+0.3% +$3.01K 0.02% 637
2022
Q2
$936K Buy
21,284
+691
+3% +$29.9K 0.02% 596
2022
Q1
$821K Sell
20,593
-14
-0.1% -$499 0.01% 672
2021
Q4
$829K Sell
20,607
-632
-3% -$23.6K 0.01% 686
2021
Q3
$864K Sell
21,239
-238
-1% -$9.95K 0.02% 628
2021
Q2
$975K Buy
21,477
+7,502
+54% +$332K 0.02% 608
2021
Q1
$583K Sell
13,975
-3,065
-18% -$140K 0.01% 705
2020
Q4
$728K Buy
+17,040
New +$613K 0.02% 585

Other funds holding HALO

Xponance's HALO Position: Q1 2026 in Review

Xponance increased its Halozyme (HALO) stake by 13% in Q1 2026, buying an estimated $217K and bringing the position to 26,039 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #609.

Xponance first reported a position in HALO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.86M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Xponance held 26,039 shares of Halozyme worth $1.68M as of Q1 2026.
  • Xponance bought 3,074 Halozyme shares in Q1 2026, an estimated $217K.
  • Halozyme made up 0.01% of Xponance's portfolio in Q1 2026, its #609 holding.
  • Xponance first reported a position in Halozyme in Q4 2020 and has held it in 22 quarters since.
  • Xponance's Halozyme position peaked at $1.86M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.